Clinical Trial Update: Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)

View source ↗

Summary

The RESOLVE trial, evaluating somatostatin analogues as a volume-reducing treatment for polycystic liver disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Liver Disease

Snippet

Sponsor: Radboud University Medical Center | Conditions: Polycystic Liver Disease | Status: COMPLETED